147
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The Efficacy of Dose Increments of Botulinum Toxin A in the Treatment of Childhood Esotropia

, , &
Pages 113-120 | Published online: 12 Jan 2021

References

  • Comella CL, Pullman SL. Botulinum toxins in neurological disease. Muscle Nerve. 2004;29(5):628–644. doi:10.1002/mus.20033
  • Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry. 2004;75(7):951–957. doi:10.1136/jnnp.2003.034702
  • Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734–770.
  • Dutton JJ, Fowler AM. Botulinum toxin in ophthalmology. Surv Ophthalmol. 2007;52(1):13–31. doi:10.1016/j.survophthal.2006.10.003
  • Rowe FJ, Noonan CP. Botulinum toxin for the treatment of strabismus (Review). Cochrane Database Syst Rev. 2017;3.
  • Talebnejad MR, Tahamtan M, Nowroozzadeh MH. Botulinum toxin injection for treatment of acute traumatic superior oblique muscle palsy. J Ophthalmic Vis Res. 2015;10(3):263–267. doi:10.4103/2008-322X.170350
  • Al Taisan AA, Al Shamlan FT, Al Mulhim AK, Alsomali AI, Al Owaifeer AM. Botulinum toxin; indications, success rates and complications in the management of horizontal strabismus in Saudi Arabia. J Clin Ophthalmol. 2018;02(01). doi:10.35841/clinical-ophthalmology.2.1.32-37
  • Scott AB, Magoon EH, McNeer KW, Stager DR. Botulinum treatment of childhood strabismus. Ophthalmology. 1990;97(11):1434–1438. doi:10.1016/S0161-6420(90)32390-4
  • Abbasoglu OE, Sener EC, Sanac AS. Factors influencing success and dose-effect relation of botulinum A treatment. Eye. 1996;10(3):385–391. doi:10.1038/eye.1996.78
  • Wohlfarth K, Göschel H, Frevert J, Dengler R, Bigalke H. Botulinum A toxins: units versus units. Naunyn Schmiedebergs Arch Pharmacol. 1997;355(3):335–340. doi:10.1007/PL00004951
  • Marchetti A, Magar R, Findley L, et al. Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study. Mov Disord. 2005;20(8):937–944. doi:10.1002/mds.20468
  • Solebo AL, Austin AM, Theodorou M, Timms C, Hancox J, Adams GGW. Botulinum toxin chemodenervation for childhood strabismus in England: national and local patterns of practice. PLoS One. 2018;13(6):1–12. doi:10.1371/journal.pone.0199074
  • Chen J, Deng D, Zhong H, et al. Botulinum toxin injections combined with or without sodium hyaluronate in the absence of electromyography for the treatment of infantile esotropia: A pilot study. Eye. 2013;27(3):382–386. doi:10.1038/eye.2012.264
  • de Alba Campomanes AG, Binenbaum G, Eguiarte GC. Comparison of botulinum toxin with surgery as primary treatment for infantile esotropia. J AAPOS. 2010;14(2):111–116. doi:10.1016/j.jaapos.2009.12.162
  • Tejedor J, Gutiérrez-Carmona FJ. Botulinum toxin in the treatment of partially accommodative esotropia with high AC/A ratio. PLoS One. 2020;15(2):e0229267. doi:10.1371/journal.pone.0229267
  • Ameri A, Farzbod F, Bazvand F, et al. Botulinum toxin injection in the patients with Duane syndrome type 1. J Curr Ophthalmol. 2017;29(1):50–53. doi:10.1016/j.joco.2016.09.004
  • Tejedor J, Rodríguez JM. Early retreatment of infantile esotropia: comparison of reoperation and botulinum toxin. Br J Ophthalmol. 1999;83(7):783–787. doi:10.1136/bjo.83.7.783